Variant report
Variant | esv3471559 |
---|---|
Chromosome Location | chr5:89876083-89876817 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538779105 | chr5:89876105-89876106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558614434 | chr5:89876243-89876244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572154813 | chr5:89876266-89876267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187897696 | chr5:89876273-89876274 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554907807 | chr5:89876275-89876276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6889466 | chr5:89876304-89876305 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs140970445 | chr5:89876306-89876307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563759565 | chr5:89876307-89876308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150247114 | chr5:89876344-89876345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545165394 | chr5:89876350-89876351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs200391944 | chr5:89876357-89876358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192353880 | chr5:89876394-89876395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184989395 | chr5:89876433-89876434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547088507 | chr5:89876436-89876437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs560906353 | chr5:89876465-89876466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188928591 | chr5:89876477-89876478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550031679 | chr5:89876504-89876505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569553356 | chr5:89876512-89876513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538443211 | chr5:89876523-89876524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551906322 | chr5:89876538-89876539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181539869 | chr5:89876554-89876555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371555783 | chr5:89876556-89876557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534758858 | chr5:89876566-89876567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554689722 | chr5:89876662-89876663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574755358 | chr5:89876714-89876715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6890465 | chr5:89876755-89876756 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs112687005 | chr5:89876763-89876764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563476480 | chr5:89876764-89876765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370908608 | chr5:89876817-89876818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 19592390 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:89859400-89884200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr5:89867400-89889200 | Weak transcription | H1 Cell Line | embryonic stem cell |
3 | chr5:89868800-89884400 | Weak transcription | H9 Cell Line | embryonic stem cell |
4 | chr5:89869200-89881200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr5:89871600-89877400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr5:89872000-89881600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr5:89875800-89876400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr5:89876400-89881000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |